The Transversus Abdominis Plane Block: A Prospective Randomized Clinical Trial Using EXPAREL.
NCT ID: NCT02263963
Last Updated: 2023-02-28
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
50 participants
INTERVENTIONAL
2013-07-31
2014-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
EXPAREL Administered by Infiltration Into the TAP for Prolonged Postsurgical Analgesia in Lower Abdominal Surgeries
NCT01919190
Exparel Transversus Abdominis Plane Block vs Intrathecal Analgesia In Colorectal Surgery
NCT02356198
TAP-patients With Robotic Assisted Lap Prostatectomy
NCT01582477
PK Study of EXPAREL in Subjects Undergoing Open Spinal Fusion or Reconstructive Surgery
NCT02985762
Transversus Abdominis Plane Blocks With Abdominoplasty
NCT01278264
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
TAP Block Experal
Patient who randomized to this arm, will be blinded, TAP block will be performed under ultrasound guidance, where 20-30 ml of Exparel will be injected in transversus abdominis plane, bilaterally.
Exparel
In this arm as described above the intervention will be TAP block injection under ultrasound guidance using Exparel.
TAP Block
no intervention will be done to this arm.
No TAP Block
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Exparel
In this arm as described above the intervention will be TAP block injection under ultrasound guidance using Exparel.
TAP Block
no intervention will be done to this arm.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Elective laparoscopic colorectal resection.
Exclusion Criteria
2. Patients unable to provide informed consent
3. Patients undergoing emergency surgery.
4. Pregnant women
5. Severe liver or kidney disease (GFR 15-29 ml/min)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Spectrum Health Hospitals
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Spectrum Health
Grand Rapids, Michigan, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DDI.FY13.07
Identifier Type: OTHER
Identifier Source: secondary_id
2013-066
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.